Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. - Wikidata - wikimedia - TriplyDB

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

http://www.wikidata.org/entity/Q33404320

about

Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia Alternate considerations for current concepts in ITP.Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths Immune thrombocytopenia: recent progress in pathophysiology and treatment.Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration.The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.Does the site of platelet sequestration predict the response to splenectomy in adult patients with immune thrombocytopenic purpura?Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.Is ITP a thrombophilic disorder?Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.How we manage immune thrombocytopenia in the elderly.Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.Long-term results of splenectomy in adult chronic immune thrombocytopenia.Low-level light treatment ameliorates immune thrombocytopenia.Long-term complications of splenectomy in adult immune thrombocytopenia.Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect.Romiplostim therapy as a second-line treatment before splenectomy for refractory immune thrombocytopenia in a cirrhotic patient with iatrogenic Cushing syndrome secondary to corticosteroids.Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.Splenectomy for Immune Thrombocytopenia: Down but not out.Percentage of Memory B Lymphocytes and Regulatory T Lymphocytes in Peripheral Blood are Low but Not Predictive of Therapy outcomes in Newly Diagnosed Adult Patients with Primary Immune Thrombocytopenia.Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis.Physician Decision Making in Selection of Second-Line Treatments in Immune Thrombocytopenia in Children.Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.

P2860

Q26778773-8A9D923E-A4AF-4EBC-8F9A-42132221B668 Q30250259-73414FBF-B942-4A7E-9F08-56B2DC3D83C3 Q33407451-F5B9884F-2212-4137-935D-C1124FAFA97C Q33407813-54AFBF2B-3BB4-4E7C-AABE-8551E8408BBA Q33409622-0FF157A1-0FE9-4F3D-B16D-C64BCF470E60 Q33410348-A1029209-333D-4C1A-B8AC-A17923BC81ED Q33412266-63736881-8FD5-44C1-AF47-E4ACE9C79936 Q33413896-640609FD-333A-4CCE-ACB6-5D2B5AEFD790 Q33414722-707DE27F-4FE7-42D2-8081-D0F0652AFB79 Q33416947-B85EA629-EFF8-4367-BF34-E4F8A4746EE7 Q33417946-142E79E2-8709-47D5-9E83-2658762B6F75 Q33419605-83AAAF4D-8674-4DEA-8E1C-E140AD8077CE Q33427336-F01A15EA-E4C0-4389-A8F7-A6CFA295FA55 Q33427394-AEB6056E-EA76-44A0-9C35-8D645C9DFDA5 Q33429426-1FC16C01-FBF5-4DEE-A780-51A16891C008 Q33430258-5CA79539-5691-48D0-89AD-6E79C72444DF Q33431371-2B8E637E-DEF7-4677-AD61-89B938715D60 Q33433585-14EF182D-9A4E-4735-B3B9-E7FCBFBE88A1 Q33436100-7779F19B-9140-42E0-8624-9991BD7CA76E Q33437208-4CDE7939-6320-4D0E-BE10-457027FF9931 Q33437227-DCEA2D07-E6C0-468F-AB25-AF80EE8A457B Q33437682-1868D668-88B4-4A7C-B92F-D012FB699C7C Q33438334-E48A8012-2311-4CA7-9202-BFF0D21698A7 Q33439098-ADAF5B5B-9292-44C5-A24A-9722D2C5216B Q33441008-F3B067C0-F8D7-44DD-BDAD-09BCB0494E99 Q44988721-5077BEE9-E5C4-4667-8FD1-B61EA5117BC2 Q47367088-3CDD04F3-70C3-4D08-8CD0-1A438DEEDE76 Q47754303-80F26B16-A55B-4C88-8FBF-F9A2C708CBB2 Q50092899-75E983A3-F2B9-4660-B3CA-7CE9698EBD15 Q50224066-7CCED0D8-6314-42AB-8227-5C55B19EE867 Q52320502-9FFDEB8C-ADAC-4FB1-BD55-611766732B4E Q55332132-303F6307-6832-4066-A253-D2B256532029

P2860

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

http://www.wikidata.org/entity/Q33404320

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@ast

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@en

type

label

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@ast

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@en

prefLabel

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@ast

Splenectomy as a curative trea ...... minimum follow up of 10 years.

@en

P1433

Q33404320-15A3488E-0C28-4EAB-817A-B0C950A24C4F

P1476

Q33404320-5BA6F605-CCAD-4703-BE6D-851C58BB74EA

P2093

Q33404320-1613F5B2-E655-4BC8-8A5F-C2EA545180E5

Q33404320-561A7B87-41E0-4D59-94FF-58A22366F89B

Q33404320-7FB6BD3D-C011-42CD-95BF-212F0EF97A53

Q33404320-840370F4-9B16-4F29-8EF8-4F0A124E909A

Q33404320-87AB50D5-337C-417B-97E3-ECBAE0FC83B7

Q33404320-89062A10-EF54-4A56-A002-3211FE603009

Q33404320-A01C78EA-0ABF-43BC-8B23-B1B4C28545A6

Q33404320-A44C9DDC-FA45-493A-9726-B5646B89E97D

Q33404320-A483461C-E25C-40EE-9CEC-C30741FE2004

Q33404320-B28EE0E3-E4EA-481C-99AA-097FD861EFB9

P2860

Q33404320-0F8706A1-7BF7-4355-8EDC-19946F49D520

Q33404320-1F2AA75F-860D-4335-8F7C-C7B0E966FB87

Q33404320-240237BA-91DC-4EF6-95D6-6E5DF76E85C3

Q33404320-288451B5-1BB3-464E-99C2-BFF99C2ACE23

Q33404320-318F088D-1B3B-48B4-AAFD-2809C72383B7

Q33404320-337E0959-158D-4613-AF3E-D76F9F8B663F

Q33404320-36B97F42-050E-4450-90CB-94E537C82F04

Q33404320-3E30B9B2-4BAE-4CB5-A78D-2A61FCFEAA3B

Q33404320-5CA8681E-1886-4844-934C-60D40B3683A3

Q33404320-6B62077C-7DE9-4B0F-A5C3-81631DC0D59D

P304

Q33404320-419DACCC-3342-42B9-A505-FE4B516E9D37

P31

Q33404320-049E1726-B8AC-4F84-88DF-FFDF846B02C9

P356

Q33404320-621E6813-9EFF-4A59-8D2B-B5CDC185F18D

P433

Q33404320-A1FEAD9C-BD91-44E6-B4D3-F55A9030E38A

P478

Q33404320-322E22A5-2196-4CA5-9FD1-6C2BE575C9B8

P50

Q33404320-3DA98971-52FE-4403-9034-2F1B32A519F5

Q33404320-61F9B57B-D903-47B1-99FA-3BD843CD0C31

Q33404320-929B6632-F528-452A-BBE2-8E645DA5B374

Q33404320-9D93C060-69A8-46D8-B973-B1D725BA1E83

P577

Q33404320-DA9AAB43-0402-4283-A2C1-445B3A48E5F6

P5875

Q33404320-D55EBA9A-891A-4BB1-8DF4-4EA767FADC38

P698

Q33404320-910BA183-8E6C-4E4F-8BEC-F1E1BE588245

P921

Q33404320-51A6B6DC-F111-4837-80A2-0682E0615B19

P932

Q33404320-6F722970-252E-4C53-A0B5-4A29F00DB5A7

P356

HAEMATOL.2012.075648

P1433

P1476

Splenectomy as a curative trea ...... minimum follow up of 10 years

@en

P2093

Angelo Emanuele Catucci

http://www.w3.org/2001/XMLSchema#string

Anna Candoni

http://www.w3.org/2001/XMLSchema#string

Enrica Morra

http://www.w3.org/2001/XMLSchema#string

Eva Johansson

http://www.w3.org/2001/XMLSchema#string

Francesco Rodeghiero

http://www.w3.org/2001/XMLSchema#string

Magnus Björkholm

http://www.w3.org/2001/XMLSchema#string

Marco Ruggeri

http://www.w3.org/2001/XMLSchema#string

Michele Baccarani

http://www.w3.org/2001/XMLSchema#string

Nicola Vianelli

http://www.w3.org/2001/XMLSchema#string

Roberto Stasi

http://www.w3.org/2001/XMLSchema#string

P2860

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment

International consensus report on the investigation and management of primary immune thrombocytopenia

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

Long-term outcomes in adults with chronic ITP after splenectomy failure.

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.

Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.

P304

875-880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2012.075648

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Nicola Polverelli

Francesca Palandri

Joel K Joelsson

P577

2012-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233396356

http://www.w3.org/2001/XMLSchema#string

P698

23144195

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia

P932

3669442

http://www.w3.org/2001/XMLSchema#string